UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 627

Sortiert nach

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.299-302

2005

Volltextzugriff (PDF)

Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis

Annals of the rheumatic diseases, 2005-08, Vol.64 (8), p.1145-1149

2005

Volltextzugriff (PDF)

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

Annals of the rheumatic diseases, 2004-09, Vol.63 (9), p.1155-1158

2004

Volltextzugriff (PDF)

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

Annals of the rheumatic diseases, 2000-12, Vol.59 (12), p.945-953

2000

Volltextzugriff (PDF)

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Annals of the rheumatic diseases, 2003-09, Vol.62 (9), p.829-834

2003

Volltextzugriff (PDF)

Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy

Annals of the rheumatic diseases, 2005-04, Vol.64 (4), p.529-536

2005

Volltextzugriff (PDF)

Characterisation of human knee meniscus cell phenotype

Osteoarthritis and cartilage, 2005-07, Vol.13 (7), p.548-560

2005

Volltextzugriff (PDF)

Voiding camp: A successful and unique bladder rehabilitation program for children with urinary incontinence

Journal of pediatric urology, 2024-05

2024

Volltextzugriff (PDF)

Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

Annals of the rheumatic diseases, 2002-03, Vol.61 (3), p.207-212

2002

Volltextzugriff (PDF)

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn’s disease

Annals of the rheumatic diseases, 2005-06, Vol.64 (6), p.930-935

2005

Volltextzugriff (PDF)

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study

Annals of the rheumatic diseases, 2000-06, Vol.59 (6), p.428-433

2000

Volltextzugriff (PDF)

Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.321-324

2005

Volltextzugriff (PDF)

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

Annals of the rheumatic diseases, 2004-12, Vol.63 (12), p.1594-1600

2004

Volltextzugriff (PDF)

Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy

Annals of the rheumatic diseases, 2003-05, Vol.62 (5), p.455-459

2003

Volltextzugriff (PDF)

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing

Annals of the rheumatic diseases, 2001-12, Vol.60 (12), p.1131-1136

2001

Volltextzugriff (PDF)

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα

Annals of the rheumatic diseases, 2001-08, Vol.60 (8), p.750-755

2001

Volltextzugriff (PDF)

Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment

Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1542-1549

2005

Volltextzugriff (PDF)

Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association

Journal of rheumatology, 2000-12, Vol.27 (12), p.2860

2000

Volltextzugriff (PDF)

Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

Annals of the rheumatic diseases, 2002-10, Vol.61 (10), p.929-933

2002

Volltextzugriff (PDF)

Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies

Annals of the rheumatic diseases, 2005-09, Vol.64 (9), p.1316-1320

2005

Volltextzugriff (PDF)

Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks

Annals of the rheumatic diseases, 2001-08, Vol.60 (8), p.781-790

2001

Volltextzugriff (PDF)

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study

Rheumatology (Oxford, England), 2005-04, Vol.44 (4), p.465-468

2005

Volltextzugriff (PDF)

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

Annals of the rheumatic diseases, 2002-12, Vol.61 (12), p.1090-1094

2002

Volltextzugriff (PDF)

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.330-332

2005

Volltextzugriff (PDF)

Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs

Clinical rheumatology, 2002-06, Vol.21 (3), p.231-243

2002

Volltextzugriff (PDF)

1 – 25 von 627

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(511)
Mit Volltextzugriff
(451)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(421)
Science & Technology
(377)
Life Sciences & Biomedicine
(359)
Male
(246)
Female
(235)
Biological And Medical Sciences
(197)
Rheumatology
(195)
Adult
(186)
Medical Sciences
(184)
Middle Aged
(179)
Aged
(127)
Adolescent
(102)
Diseases Of The Osteoarticular System
(85)
Child
(73)
Inflammatory Joint Diseases
(69)
Hematology
(56)
Arthritis, Rheumatoid - Immunology
(54)
Child, Preschool
(54)
Immunology
(52)
Treatment Outcome
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of The Rheumatic Diseases
(63)
Journal Of Rheumatology
(61)
Clinical And Experimental Rheumatology
(33)
Blood
(29)
Arthritis And Rheumatism
(26)
The Lancet
(20)
Arthritis Research & Therapy
(17)
Bone Marrow Transplantation
(17)
Clinical Rheumatology
(16)
Osteoarthritis And Cartilage
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy

Characterisation of human knee meniscus cell phenotype

Voiding camp: A successful and unique bladder rehabilitation program for children with urinary incontinence

Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn’s disease

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study

Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα

Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment

Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association

Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies

Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs

Suchergebnisse filtern